Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-28

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rituximab in combination with methotrexate versus methotrexate alone for active rheumatoid arthritis has completed, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Rituximab (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-06-28